Tag: February

Clearances, Approvals, Updates, and Recommendations Japan Approves Dupilumab for Chronic Spontaneous Urticaria Japan is the first country in the world to approve dupilumab for the treatment of chronic spontaneous urticaria (CSU). Lifileucel Receives FDA Accelerated Approval for Advanced Melanoma Lifileucel is a tumor-derived autologous T cell immunotherapy. ICYMI: FDA Approves Third Interchangeable Humira Biosimilar Simlandi […]